Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Polaryx Therapeutics, Inc.

NASDAQ: PLYX · Life Sciences · 2 alerts · CIK 2075320

Share price
$1.67Close, Nov 16
Market cap
$83.2M
Shares outstanding
49.85MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Polaryx Therapeutics, Inc. filings on SEC EDGAR ↗

4:17 PM ET 10-Q
Financial Results

Polaryx Therapeutics Q3 2026 Results: Net Loss of $3.33M, Loss Widens

Polaryx Therapeutics reported a net loss of $7.3 million for the nine months ended September 30, 2026, compared to $7.5 million in the prior year period. The company maintains a going concern warning due to recurring losses and negative operating cash flows, though it successfully raised $9.8 million through common stock issuances during the period.

Key figure
Net loss $3.33M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.